| PROC |
PROC: Vitamin K-dependent protein C precursor |
ANPEP |
ANPEP, APN, CD13, PEPN: Aminopeptidase N |
1.387 |
Evidence |
|
| F10 |
F10: Coagulation factor X precursor |
ANPEP |
ANPEP, APN, CD13, PEPN: Aminopeptidase N |
1.387 |
Evidence |
|
| F9 |
F9: Coagulation factor IX precursor |
LCAT |
LCAT: Phosphatidylcholine-sterol acyltransferase precursor |
1.387 |
Evidence |
|
| F2 |
F2: Prothrombin precursor |
ANPEP |
ANPEP, APN, CD13, PEPN: Aminopeptidase N |
1.387 |
Evidence |
|
| SYK |
SYK: Tyrosine-protein kinase SYK |
RHOG |
RHOG, ARHG: Rho-related GTP-binding protein RhoG precursor |
1.387 |
Evidence |
|
| NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
CDC42 |
CDC42: Cell division control protein 42 homolog precursor |
1.387 |
Evidence |
|
| NCF1 |
Neutrophil cytosolic factor 1 variant (Fragment) |
TMSB4X |
TMSB4X, TB4X, THYB4, TMSB4: Thymosin beta-4 |
1.387 |
Evidence |
|
| ALOX5 |
ALOX5, LOG5: Arachidonate 5-lipoxygenase |
TMSB4X |
TMSB4X, TB4X, THYB4, TMSB4: Thymosin beta-4 |
1.387 |
Evidence |
|
| CTSG |
CTSG: Cathepsin G precursor |
SERPINB1 |
SERPINB1, ELANH2, MNEI, PI2: Leukocyte elastase inhibitor |
1.385 |
Evidence |
|
| SIRPB1 |
SIRPB1: Signal regulatory protein beta-1 precursor |
B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
1.385 |
Evidence |
|
| CNAP1 |
NCAPD2, CAPD2, CNAP1, KIAA0159: Condensin complex subunit 1 |
SNAPC4 |
SNAPC4, SNAP190: snRNA-activating protein complex subunit 4 |
1.385 |
Evidence |
|
| SQSTM1 |
SQSTM1: Uncharacterized protein SQSTM1 |
RHEB |
RHEB, RHEB2: GTP-binding protein Rheb precursor |
1.385 |
Evidence |
|
| RELB |
RELB: Transcription factor RelB |
CHD4 |
CHD4: Chromodomain-helicase-DNA-binding protein 4 |
1.385 |
Evidence |
|
| RAB4B |
RAB4B, PP1596: Ras-related protein Rab-4B |
SNX1 |
SNX1: Sorting nexin-1 |
1.385 |
Evidence |
|
| ADAR |
ADAR, ADAR1, DSRAD, G1P1, IFI4: Double-stranded RNA-specific adenosine deaminase |
MXD4 |
MXD4, MAD4: Max-interacting transcriptional repressor MAD4 |
1.385 |
Evidence |
|
| ARHGDIB |
ARHGDIB, GDIA2, GDID4, RAP1GN1: Rho GDP-dissociation inhibitor 2 |
LDLRAP1 |
LDLRAP1, ARH: Low density lipoprotein receptor adapter protein 1 |
1.385 |
Evidence |
|
| PCGF4 |
BMI1, PCGF4, RNF51: Polycomb complex protein BMI-1 |
RING1 |
RING1, RNF1: E3 ubiquitin-protein ligase RING1 |
1.385 |
Evidence |
|
| CNR2 |
CNR2: Cannabinoid receptor 2 |
MC1R |
IPI00552844 |
1.385 |
Evidence |
|
| POLD1 |
POLD1, POLD: DNA polymerase delta catalytic subunit |
POLM |
POLM: DNA polymerase mu |
1.385 |
Evidence |
|
| DRD5 |
DRD5, DRD1B, DRD1L2: D(1B) dopamine receptor |
OR2B2 |
OR2B2, OR2B9: Olfactory receptor 2B2 |
1.385 |
Evidence |
|
| ADRA2B |
ADRA2B, ADRA2L1, ADRA2RL1: Alpha-2B adrenergic receptor |
EDG7 |
EDG7, LPA3: Lysophosphatidic acid receptor Edg-7 |
1.385 |
Evidence |
|
| CFH |
CFH, HF, HF1, HF2: Complement factor H precursor |
CFHR4 |
CFHR4, CFHL4, FHR4: Complement factor H-related protein 4 precursor |
1.385 |
Evidence |
|
| CHRM2 |
CHRM2: Muscarinic acetylcholine receptor M2 |
CNR2 |
CNR2: Cannabinoid receptor 2 |
1.385 |
Evidence |
|
| RB1 |
RB1: Retinoblastoma-associated protein |
TBP |
TBP, GTF2D1, TF2D, TFIID: TATA-box-binding protein |
1.385 |
Evidence |
O
|
| EDG6 |
EDG6: Sphingosine 1-phosphate receptor Edg-6 |
BLR1 |
BLR1, CXCR5, MDR15: C-X-C chemokine receptor type 5 |
1.385 |
Evidence |
|